Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Incidence and risk factors of major bleeding following major orthopaedic surgery with fondaparinux thromboprophylaxis. A time-to-event analysis.

Zufferey PJ, Ollier E, Delavenne X, Laporte S, Mismetti P, Duffull SB.

Br J Clin Pharmacol. 2018 Oct;84(10):2242-2251. doi: 10.1111/bcp.13663. Epub 2018 Jul 14.

PMID:
29877590
2.

Statistical controversies in clinical research: limitations of open-label studies assessing antiangiogenic therapies with regard to evaluation of vascular adverse drug events-a meta-analysis.

Trone JC, Ollier E, Chapelle C, Bertoletti L, Cucherat M, Mismetti P, Magné N, Laporte S.

Ann Oncol. 2018 Apr 1;29(4):803-811. doi: 10.1093/annonc/mdy035.

PMID:
29415169
3.

Bone, muscle, and metabolic parameters predict survival in patients with synchronous bone metastases from lung cancers.

Chambard L, Girard N, Ollier E, Rousseau JC, Duboeuf F, Carlier MC, Brevet M, Szulc P, Pialat JB, Wegrzyn J, Clezardin P, Confavreux CB.

Bone. 2018 Mar;108:202-209. doi: 10.1016/j.bone.2018.01.004. Epub 2018 Jan 11.

PMID:
29337225
4.

Is tranexamic acid exposure related to blood loss in hip arthroplasty? A pharmacokinetic-pharmacodynamic study.

Lanoiselée J, Zufferey PJ, Ollier E, Hodin S, Delavenne X; PeriOpeRative Tranexamic acid in hip arthrOplasty (PORTO) study investigators.

Br J Clin Pharmacol. 2018 Feb;84(2):310-319. doi: 10.1111/bcp.13460. Epub 2017 Nov 28.

PMID:
29193211
5.

Navigating the highlights of phase III trials: a watchful eye on evidence-based radiotherapy.

Trone JC, Espenel S, Rehailia-Blanchard A, Guillaume E, Vial N, Rancoule C, Rodriguez-Lafrasse C, Ben Mrad M, El Meddeb Hamrouni A, Ollier E, Chargari C, Deutsch E, Vallard A, Magné N.

Ann Oncol. 2017 Nov 1;28(11):2691-2697. doi: 10.1093/annonc/mdx347. Review.

PMID:
29045516
6.

Outcomes of cup revision for ilio-psoas impingement after total hip arthroplasty: Retrospective study of 46 patients.

Batailler C, Bonin N, M Wettstein, Nogier A, Martres S, Ollier E, May O, Lustig S; French Arthroscopy Society (SFA).

Orthop Traumatol Surg Res. 2017 Dec;103(8):1147-1153. doi: 10.1016/j.otsr.2017.07.021. Epub 2017 Sep 22.

PMID:
28951281
7.

Dual "mAb" HER family blockade in head and neck cancer human cell lines combined with photon therapy.

Guy JB, Méry B, Ollier E, Espenel S, Vallard A, Wozny AS, Simonet S, Lauret A, Battiston-Montagne P, Ardail D, Alphonse G, Rancoule C, Rodriguez-Lafrasse C, Magné N.

Sci Rep. 2017 Sep 22;7(1):12207. doi: 10.1038/s41598-017-12367-7.

8.

Endoscopic or arthroscopic iliopsoas tenotomy for iliopsoas impingement following total hip replacement. A prospective multicenter 64-case series.

Guicherd W, Bonin N, Gicquel T, Gedouin JE, Flecher X, Wettstein M, Thaunat M, Prevost N, Ollier E, May O; French Arthroscopy Society.

Orthop Traumatol Surg Res. 2017 Dec;103(8S):S207-S214. doi: 10.1016/j.otsr.2017.09.007. Epub 2017 Sep 13.

PMID:
28917519
9.

Assessment of clinically relevant bleeding as a surrogate outcome for major bleeding: validation by meta-analysis of randomized controlled trials.

Laporte S, Chapelle C, Bertoletti L, Ollier E, Zufferey P, Lega JC, Merah A, Décousus H, Schulman S, Meyer G, Cucherat M, Mismetti P.

J Thromb Haemost. 2017 Aug;15(8):1547-1558. doi: 10.1111/jth.13740. Epub 2017 Jul 5. Review.

PMID:
28544422
10.

Pharmacokinetic/pharmacodynamic model for unfractionated heparin dosing during cardiopulmonary bypass.

Delavenne X, Ollier E, Chollet S, Sandri F, Lanoiselée J, Hodin S, Montmartin A, Fuzellier JF, Mismetti P, Gergelé L.

Br J Anaesth. 2017 May 1;118(5):705-712. doi: 10.1093/bja/aex044.

11.

Anti-phospholipase A2 receptor antibody levels at diagnosis predicts spontaneous remission of idiopathic membranous nephropathy.

Jullien P, Seitz Polski B, Maillard N, Thibaudin D, Laurent B, Ollier E, Alamartine E, Lambeau G, Mariat C.

Clin Kidney J. 2017 Apr;10(2):209-214. doi: 10.1093/ckj/sfw121. Epub 2017 Feb 20.

12.

Analysis of temozolomide resistance in low-grade gliomas using a mechanistic mathematical model.

Ollier E, Mazzocco P, Ricard D, Kaloshi G, Idbaih A, Alentorn A, Psimaras D, Honnorat J, Delattre JY, Grenier E, Ducray F, Samson A.

Fundam Clin Pharmacol. 2017 Jun;31(3):347-358. doi: 10.1111/fcp.12259. Epub 2017 Jan 24.

PMID:
27933657
13.

Effect of Activated Charcoal on Rivaroxaban Complex Absorption.

Ollier E, Hodin S, Lanoiselée J, Escal J, Accassat S, De Magalhaes E, Basset T, Bertoletti L, Mismetti P, Delavenne X.

Clin Pharmacokinet. 2017 Jul;56(7):793-801. doi: 10.1007/s40262-016-0485-1.

PMID:
27910037
14.

Direct oral anticoagulants: Current indications and unmet needs in the treatment of venous thromboembolism.

Bertoletti L, Ollier E, Duvillard C, Delavenne X, Beyens MN, De Magalhaes E, Bellet F, Basset T, Mismetti P, Laporte S.

Pharmacol Res. 2017 Apr;118:33-42. doi: 10.1016/j.phrs.2016.06.023. Epub 2016 Jun 24. Review.

PMID:
27350265
15.

Correlation between anthropometric parameters and acute skin toxicity in breast cancer radiotherapy patients: a pilot assessment study.

Méry B, Vallard A, Trone JC, Pacaut C, Guy JB, Espenel S, Langrand-Escure J, Ollier E, Wang G, Diao P, Bigot L, Mengue Ndong S, Bosacki C, Ben Mrad M, Magné N.

Br J Radiol. 2015;88(1055):20150414. doi: 10.1259/bjr.20150414. Epub 2015 Sep 22.

16.

In vitro and in vivo evaluation of drug-drug interaction between dabigatran and proton pump inhibitors.

Ollier E, Hodin S, Basset T, Accassat S, Bertoletti L, Mismetti P, Delavenne X.

Fundam Clin Pharmacol. 2015 Dec;29(6):604-14. doi: 10.1111/fcp.12154. Epub 2015 Oct 7.

PMID:
26392328
17.

Dosimetric study of volumetric arc modulation with RapidArc and intensity-modulated radiotherapy in patients with cervical cancer and comparison with 3-dimensional conformal technique for definitive radiotherapy in patients with cervical cancer.

Guy JB, Falk AT, Auberdiac P, Cartier L, Vallard A, Ollier E, Trone JC, Khodri M, Chargari C, Magné N.

Med Dosim. 2016 Spring;41(1):9-14. doi: 10.1016/j.meddos.2015.06.002. Epub 2015 Jul 23.

PMID:
26212351
18.

[Influence of anticoagulant therapy during pregnancy on the peripartum and anesthesia delivery terms].

Boilot T, Raia-Barjat T, Ollier E, Chapelle C, Laporte S, Chauleur C.

Gynecol Obstet Fertil. 2015 Jul-Aug;43(7-8):502-8. doi: 10.1016/j.gyobfe.2015.06.005. Epub 2015 Jul 17. French.

PMID:
26190567
19.

Tunable thermal conductivity of thin films of polycrystalline AlN by structural inhomogeneity and interfacial oxidation.

Jaramillo-Fernandez J, Ordonez-Miranda J, Ollier E, Volz S.

Phys Chem Chem Phys. 2015 Mar 28;17(12):8125-37. doi: 10.1039/c4cp05838k.

PMID:
25729791
20.

Population pharmacokinetic model of free and total ropivacaine after transversus abdominis plane nerve block in patients undergoing liver resection.

Ollier E, Heritier F, Bonnet C, Hodin S, Beauchesne B, Molliex S, Delavenne X.

Br J Clin Pharmacol. 2015 Jul;80(1):67-74. doi: 10.1111/bcp.12582. Epub 2015 May 28.

21.

[Direct oral anticoagulant, useful pharmacological characteristics in clinical practice].

Ollier E, Delavenne X.

Therapie. 2015 May-Jun;70(3):243-9. doi: 10.2515/therapie/2014206. Epub 2014 Dec 24. French.

PMID:
25534517
22.

VHF NEMS-CMOS piezoresistive resonators for advanced sensing applications.

Arcamone J, Dupré C, Arndt G, Colinet E, Hentz S, Ollier E, Duraffourg L.

Nanotechnology. 2014 Oct 31;25(43):435501. doi: 10.1088/0957-4484/25/43/435501. Epub 2014 Oct 7.

PMID:
25288224
23.

High frequency top-down junction-less silicon nanowire resonators.

Koumela A, Hentz S, Mercier D, Dupré C, Ollier E, Feng PX, Purcell ST, Duraffourg L.

Nanotechnology. 2013 Nov 1;24(43):435203. doi: 10.1088/0957-4484/24/43/435203. Epub 2013 Oct 9.

PMID:
24107321
24.

A semi-mechanistic absorption model to evaluate drug-drug interaction with dabigatran: application with clarithromycin.

Delavenne X, Ollier E, Basset T, Bertoletti L, Accassat S, Garcin A, Laporte S, Zufferey P, Mismetti P.

Br J Clin Pharmacol. 2013 Jul;76(1):107-13. doi: 10.1111/bcp.12055.

25.

Piezoresistance of top-down suspended Si nanowires.

Koumela A, Mercier D, Dupré C, Jourdan G, Marcoux C, Ollier E, Purcell ST, Duraffourg L.

Nanotechnology. 2011 Sep 30;22(39):395701. doi: 10.1088/0957-4484/22/39/395701. Epub 2011 Sep 2.

PMID:
21891838
26.

Forced G1-phase reduction alters mode of division, neuron number, and laminar phenotype in the cerebral cortex.

Pilaz LJ, Patti D, Marcy G, Ollier E, Pfister S, Douglas RJ, Betizeau M, Gautier E, Cortay V, Doerflinger N, Kennedy H, Dehay C.

Proc Natl Acad Sci U S A. 2009 Dec 22;106(51):21924-9. doi: 10.1073/pnas.0909894106. Epub 2009 Dec 3.

Supplemental Content

Loading ...
Support Center